Risk alert: FDA restricts sale of Essure Permanent Birth Control

April 9, 2018

The FDA has restricted the sale and distribution of the Essure Permanent Birth Control System to only physicians and health care facilities that agree to use the FDA-approved “Patient-Doctor Discussion Checklist — Acceptance of Risk and Informed Decision Acknowledgement.”

Health care professionals must review this checklist with patients and give them the opportunity to sign it before Essure implantation.    

This new safety measure has been enacted to ensure that women who receive Essure have been informed of the risks and benefits of the device. 

Learn more

 

Previous Video
8 Tips for Improving Patient Satisfaction
8 Tips for Improving Patient Satisfaction

TMLT Risk Management manager Tanya Babitch offers 8 tips for improving patient satisfaction with a physicia...

Next Video
5 Tips to Minimize Patient Frustration
5 Tips to Minimize Patient Frustration

TMLT Risk Management manager Robin Desrocher provides helpful tips to help minimize patient frustration in ...